Radionuclide monitoring of targeted therapy of iodine-negative differentiated thyroid cancer
Background. Current management of treating iodine-negative metastases of differentiated thyroid cancer has its features. In recent years, tyrosine kinase inhibitors (sorafenib, sunitinib) have been registered and indicated to treat refractory forms of differentiated thyroid cancer in Ukraine. Howeve...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
National Academy of Medical Sciences of Ukraine. Grigoriev Institute for Medical Radiology and Oncology
2021-03-01
|
| Series: | Український радіологічний та онкологічний журнал |
| Subjects: | |
| Online Access: | https://ukroj.com/index.php/journal/article/view/79 |